First-in-human study to assess safety and tolerability of a single subcutaneous dose of SAR441255 in lean to overweight subjects

Trial Identifier: TDU15478
Sponsor: Sanofi
Start Date: April 2019
Primary Completion Date: September 2019
Study Completion Date: September 2019
Condition: Obesity; Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
United States, Tennessee Knoxville, Tennessee, United States, 37920